Viz.ai Stock

www.viz.aiHealthcare / Healthcare softwareFounded: 2016Funding to Date: $253.45MM

Viz.ai, founded in 2016, is an AI-driven modern care coordination technology designed to improve how healthcare is delivered. The Viz Platform features advanced deep learning software that analyzes medical imaging, aiming to accelerate a diagnosis, and increase the speed of diffusion of medical innovation.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Viz.ai, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Viz.ai’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Viz.ai.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Chris Mansi
Co-Founder, Chief Executive Officer & Board Member
Julie Skaff
Chief Operating Officer
David Golan
Co-Founder, Chief Technology Officer & Board Member
Gad Sakin
Chief Product Officer and General Manager
Kurt Blasena
Chief Revenue Officer
Jayme Strauss
Chief Clinical Officer
David Kizner
Chief Privacy Officer & General Counsel
Jieun Choe
Chief Marketing Officer

Board Members

Mamoon Hamid
Kleiner Perkins
Kevin Ding
DHVC
Neil Shah
Greenoaks Capital Partners
Nikhil Sachdev
Insight Partners
Rory O'Driscoll
Scale Venture Partners

Viz.ai stock FAQs

plusminus

Can you buy Viz.ai stock?

As Viz.ai is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Viz.ai, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Viz.ai stock?

To invest in a private company like Viz.ai through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Viz.ai stock?

Yes, you may be able to sell your Viz.ai stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Viz.ai stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Viz.ai stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Viz.ai a public company?

No, Viz.ai is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Viz.ai’s stock price?

Viz.ai is a privately held company and therefore does not have a public stock price. However, you may access Viz.ai’s private market stock price with Forge Data.
plusminus

What is Viz.ai’s stock ticker symbol?

Viz.ai does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Viz.ai has received a de novo approval from the U.S. Food and Drug Administration (FDA) for its new artificial intelligence (AI) algorithm designed to identify signs of hypertrophic cardiomyopathy (HCM) in routine electrocardiograms (ECGs).
Viz.ai has presented three new studies demonstrating the real-world impact of its AI-driven stroke technology. The studies highlight the superior performance of the Viz LVO solution in detecting large vessel occlusion on CT angiography for acute stroke, the value of data in visualising disparities in care and redistributing resources to increase access to stroke care in rural areas, and the successful implementation of Viz.ai's AI-powered solutions to assess and treat chronic subdural haematoma patients.
Named a Unicorn sub-community member, Viz.ai will be offering unique insights and solutions to global healthcare-related issues and how to harness the power of artificial intelligence for common good.
CIBC Innovation Banking has provided $40M in growth capital financing to Viz.ai, a San Francisco-based company that uses artificial intelligence to expedite disease detection and improve patient care. The funding will be used to expand Viz.ai's AI-powered care coordination platform and fuel its expansion, including potential acquisitions.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.